Venous thromboembolism in ischaemic stroke in Asia

نویسندگان

  • KS Tan
  • AR Rashid
  • CT Tan
چکیده

Background: There are extensive studies indicating that deep venous thrombosis and pulmonary embolism contributes to significant morbidity and mortality after acute ischaemic stroke in the West, with established guidelines for prophylaxis. The situation is less clear in Asia. Accordingly, a literature search was performed to review the available evidence. Methods: A search was performed with all published materials in PubMed, Directory of Open Access Journals and BioMed Central, using the following keywords “venous thromboembolism”, “Asia”, “stroke”, “deep venous thrombosis” and “pulmonary embolism”. Systematic and non-systematic studies, previous review articles with their related references were also reviewed. Results: Wide ranging prevalence of venous thromboembolism has been reported after acute ischaemic stroke in Asia, 1% or less in clinical studies, 4.8% to 45% with imaging studies. The prevalence is lower as compared to Caucasian populations, 1.5% to 5.6% in clinical studies, 11% to 80% with imaging studies. Conclusion: The problem of venous thromboembolism is not negligible in Asia. There is a need for future studies in Asia with larger sample sizes. Antiplatelet drugs should be routinely used as prophylaxis while compression stockings applied for those with significant limb weakness. Prophylactic anticoagulation may be considered in those with additional risk factors. Neurology Asia 2008; 13 : 95 – 101 Address correspondence to: Dr KS Tan, c/o Neurology Laboratory, University of Malaya Medical Centre, Kuala Lumpur 59100, Malaysia. E-mail: tanks@ ummc.edu.my INTRODUCTION A review of the evidence available for venous thromboembolism after acute ischaemic stroke in Asian patients have not been performed to date despite the continuing controversy that venous thromboembolism in stroke patients was less frequent among Asians compared to Caucasians. Accordingly, this review aims to assemble and interpret the accumulated evidence of venous thromboembolism among stroke patients in Asia, compare the current evidence with the Western literature on the background of recent therapeutic trials and to make clinical recommendations. Previous studies have suggested that venous thromboembolism in stroke patients was likely to be less frequent among Asians compared to Caucasians. Evidence for this came indirectly from various studies. A comparative study within multi-ethnic California revealed that the risk ratio for annual venous thromboembolism for Asians was 0.2 compared with Caucasians.1 Autopsy studies were also noted to be lower in Japanese (0.7%) compared with North Americans (15%).2 The annual incidence of venous thromboembolism in Hong Kong Chinese was estimated at 16.6 events per 100,000 population. This incidence was 10 to 20% of the rates found in Western populations.3 In addition, other studies in Asia noted that venous thromboembolism incidence in multi-ethnic Singapore among hospitalized patients was 15.8 per 10,000 admissions4 while its prevalence in post operative conditions in Malaysia and Singapore such as hip surgery5, colorectal surgery6, cranial procedures7 and general surgery8 were 14%, 3%, 5% and 2.2% respectively. A previous review in Asia9 noted a similar wide ranging prevalence in post-operative settings with ranges between 3%-63%. Overall, these rates were lower compared with Western data, which routinely showed prevalence of between 28-80% in similar clinical situations. However, no previous critical evaluation has been performed among stroke patients in Asia and to our knowledge, this is the first of such a review.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study

OBJECTIVE To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs. DESIGN Population based nested case-control study. SETTING Ontario, Canada. PARTICIPANTS 91,378 older adults with a history of physician diagnosed retinal disease identified between 1 April 2006 and 31 March 2011. Cases were 1477 patients ...

متن کامل

Migraine and risk of cardiovascular diseases: Danish population based matched cohort study

OBJECTIVE To examine the risks of myocardial infarction, stroke (ischaemic and haemorrhagic), peripheral artery disease, venous thromboembolism, atrial fibrillation or atrial flutter, and heart failure in patients with migraine and in a general population comparison cohort. DESIGN Nationwide, population based cohort study. SETTING All Danish hospitals and hospital outpatient clinics from 19...

متن کامل

Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.

OBJECTIVES To compare the efficacy, safety, and overall risk-benefit profile of enoxaparin and unfractionated heparin (UFH) prophylaxis of venous thromboembolic complications in patients with acute ischaemic stroke. METHODS Patients with ischaemic stroke resulting in lower-limb paralysis lasting for at least 24 h and necessitating bedrest, were randomized within 48 h of the onset of stroke, a...

متن کامل

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

BACKGROUND Venous thromboembolism prophylaxis with low molecular weight heparin or unfractionated heparin is recommended in acute ischaemic stroke, but which regimen provides optimum treatment is uncertain. We aimed to compare the efficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke. METHODS 1762 patients with acute ischaemic stroke who were unable to...

متن کامل

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials

BACKGROUND Many international guidelines on the prevention of venous thromboembolism recommend targeting heparin treatment at patients with stroke who have a high risk of venous thrombotic events or a low risk of haemorrhagic events. We sought to identify reliable methods to target anticoagulant treatment and so improve the chance of avoiding death or dependence after stroke. METHODS We obtai...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009